GlassScriptPhysician profile
John F Morrison
NPI 1447489620
$32,715.90
in general payments reported to CMS, 2019-2025
34 companies · $19K in 2025
The $19K reported for 2025 was more than what 89% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $382 · 2021: $1,759 · 2022: $1,764 · 2023: $1,195 · 2024: $8,358 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $3,312 · Food and Beverage: $2,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,500.00 |
| Travel and Lodging | $3,311.74 |
| Food and Beverage | $2,325.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgentec | $22,500.00 | 2024-2025 | Hydroputty, Hydrofiber, Tilink |
| Stryker Corporation | $3,116.15 | 2023-2025 | Everest Spinal System, Niagara Lateral Access System, N/A |
| Corelink, LLC | $1,005.67 | 2019-2022 | |
| Medtronic, INC. | $896.68 | 2022-2023 | Midas Rex, Cd Horizon Spinal System, Mazor X System |
| Centinel Spine, LLC | $774.39 | 2022 | |
| Abbott Laboratories | $747.37 | 2020-2023 | Proclaim, Prodigy |
| Nexxt Spine LLC | $553.12 | 2025 | Nexxt Spine Product Portfolio, Saxxony System, Expandable Lateral |
| Relievant Medsystems, INC. | $485.89 | 2021 | |
| Wenzel Spine, INC. | $455.62 | 2024-2025 | Varilift, Varilift-Lx |
| Si-Bone, INC. | $396.03 | 2019-2022 | |
| Zavation Medical Products, LLC | $290.04 | 2023-2024 | |
| Livanova USA, INC. | $172.88 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $161.41 | 2021-2022 | |
| Integra Lifesciences Corporation | $151.62 | 2019-2023 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
| Nalu Medical, INC. | $125.34 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $118.17 | 2021 | |
| Medtronic USA, INC. | $108.69 | 2019-2020 | |
| Flowonix Medical Incorporated | $100.40 | 2019 | |
| Boston Scientific Corporation | $74.78 | 2022-2024 | Superion Indirect Decompression System |
| Integrity Implants INC. | $73.46 | 2020-2021 | |
| Penumbra, INC. | $71.09 | 2019 | |
| Orthofix Medical, INC. | $65.78 | 2024-2025 | Spinal-Stim |
| Baxter Healthcare | $52.58 | 2022-2023 | Floseal |
| Ossdsign USA Incorporated | $39.28 | 2024 | |
| Abbvie INC. | $34.86 | 2024 | |
| Djo, LLC | $25.40 | 2025 | Cmf |
| Intrinsic Therapeutics | $17.54 | 2021 | |
| Zimvie INC. | $16.03 | 2022 | |
| Osteomed LLC | $15.60 | 2021 | |
| Merck Sharp & Dohme LLC | $15.42 | 2022 | |
| Morphosys, US INC. | $15.36 | 2021 | |
| Zimmer Biomet Holdings, INC. | $14.62 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.19 | 2022 | |
| Vertos Medical, INC. | $11.44 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.